id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0026-0004,FDA,FDA-2011-N-0026,"Reference 1 - Petition From Vermillion, Inc., for Reclassification of the OVA1\TM\ Test Submitted, July 22, 2009 - [Medical Devices; Immunology and Microbiology Devices: Classification of Ovarian Adnexal Mass Assessment Score Test System]",Supporting & Related Material,N-Notice (Supporting and Related Material),2011-04-27T04:00:00Z,2011,4,,,2011-04-27T14:00:24Z,,0,0,0900006480c0f54f
FDA-2011-N-0026-0003,FDA,FDA-2011-N-0026,FDA/CDRH to Division of Dockets Management,Other,M-Memorandum,2011-04-27T04:00:00Z,2011,4,2011-04-27T04:00:00Z,,2011-04-27T14:00:22Z,,0,0,0900006480c3a45d
FDA-2011-N-0026-0002,FDA,FDA-2011-N-0026,"Federal Register Volume 76, Number 77 Thursday, April 21, 2011, Rules and Regulations, FR 76 22322; Correction",Supporting & Related Material,,2011-04-21T00:00:00Z,2011,4,,,2011-04-21T19:14:16Z,,0,1,0900006480c34beb
FDA-2011-N-0026-0001,FDA,FDA-2011-N-0026,Medical Devices; Immunology and Microbiology Devices: Classification of Ovarian Adnexal Mass Assessment Score Test System,Rule,NFR-Notice of Final Rule,2011-03-23T04:00:00Z,2011,3,,,2011-03-23T19:40:15Z,2011-06620,0,0,0900006480c0ec97